Iodine-131 Anti-B1 Antibody Consolidation for Patients With Non-Hodgkin's Lymphoma Following First-line CHOP
NCT01868035
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Lymphoma, Non-Hodgkin
Interventions
DRUG:
tositumomab and iodine I-131 tositumomab
Sponsor
GlaxoSmithKline